advertisement
Value in Health 11
Showing records 1 to 11 | Display all abstracts in Value in Health47842 Identification of diseases for EQ-5d bolt-on item development: An empirical approach
Solem CT; Gu NY; Pickard AS
Value in Health 2011; 14: A428
47840 Qualitative grounding for a new patient assessment measure in ophthalmology: The functional assessment of visual tasks (vistas)
Atkinson MJ; Tally S; Heichel CW; Kozak I
Value in Health 2011; 14: A508
47834 Ocular discomfort, compliance and intra-ocular pressure (IOP) control in patients treated for glaucoma
Lafuma A; Robert J; Berdeaux G
Value in Health 2011; 14: A502
47838 Visual field evolution in glaucoma patients presenting with different disease stages: Results from an observational study
Gerlier L; Shlaen R; Wolfram C; Lamotte M; Verboven Y
Value in Health 2011; 14: A502-A503
47832 Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquad(registered trademark) instead of benzalkonium chloride in Germany
Gerlier L; Lamotte M; Lorenz K; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A503
47835 A systematic review of observational studies of patients with ocular hypertension or glaucoma receiving long term topical eye therapies
Christova L; Cottrell S; Mudge M; Tilden D; Harvey C
Value in Health 2011; 14: A510
47833 Longer term patient benefits of polyquad(registered trademark) preservative instead of benzalkonium chloride in prostaglandin eye drops: A microsimulation model in ocular hypertension and open-angle glaucoma
Gerlier L; Lamotte M; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A502
47841 Cost-effectiveness of the ex-press glaucoma filtration device in France
de Jong L; Lafuma A; Clement O; Aguade AS; Berdeaux G
Value in Health 2011; 14: A250-A251
47831 Cost of blindness in Austria
Brennig C; Schollbauer V; Walter E
Value in Health 2011; 14: A504-A505
47839 Cost-effectiveness of the ex-press glaucoma filtration device in the Netherlands
de Jong L; Lafuma A; Aguade AS; Clement O; Berdeaux G
Value in Health 2011; 14: A250
47836 Glaucoma management cost as a function of disease stage and treatment changes
Gerlier L; Shlaen R; Lorenz K; Lamotte M; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A505
